Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alnylam Pharmaceuticals
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Single or bilateral lung transplant recipients
Confirmed RSV infection
Greater than 90 days post current lung transplant
Rejection free for a minimum of 30 days
You may not be if
Known viral, bacterial, or fungal respiratory co-infection at the time of RSV diagnosis
Bronchiolitis obliterans syndrome (BOS) Grade 3 or any BOS with FEV1 that has not been stable for at least 3 months
Use of alemtuzumab within 9 months prior to screening, anti-thymocyte globulin (ATG) within 90 days of screening or prednisone or equivalent as maintenance therapy
